Unknown

Dataset Information

0

CRISPR-KO screening to identify resistance/sensitation to PI3K pathway inhibition in PTEN-null breast cancer cell lines

ABSTRACT: CRISPR-KO screening to identify resistance/sensitation to PI3K pathway inhibition in PTEN-null breast cancer cell lines

SUBMITTER: Kosuke Yusa 

PROVIDER: S-BSST189 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown CRISPR-KO screening to identify resistance/sensitation to PI3Kb+MCL1 inhibition in PTEN-null breast cancer cell line EVSA-T
| S-BSST190 | biostudies-other
Unknown Combined targeting of G protein-coupled receptor and EGF receptor signaling overcomes resistance to PI3K pathway inhibitors in PTEN-null triple negative breast cancer.
| S-EPMC7411640 | biostudies-literature
Unknown Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition.
| S-EPMC9203999 | biostudies-literature
Unknown USP10/GSK3β-mediated inhibition of PTEN drives resistance to PI3K inhibitors in breast cancer.
| S-EPMC12618074 | biostudies-literature
Unknown PTEN suppresses renal cell carcinoma proliferation and migration via inhibition of the PI3K/AKT pathway.
| S-EPMC11796115 | biostudies-literature
Unknown AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.
| S-EPMC8488980 | biostudies-literature
Unknown Targeting of GPCR and EGF receptor overcomes PI3K inhibitor resistance in PTEN-null breast cancer
| S-SCDT-EMM-2020-11987 | biostudies-other
Unknown EGFR amplification and PI3K pathway mutations identify a subset of breast cancers that synergistically respond to EGFR and PI3K inhibition.
| S-EPMC12714574 | biostudies-literature
Unknown FAK mediates a compensatory survival signal parallel to PI3K-AKT in PTEN-null T-ALL cells.
| S-EPMC7001526 | biostudies-literature
Unknown Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
| S-EPMC1198941 | biostudies-literature